NMRI mice were trained in a one-trial inhibitory avoidance task. They
were injected immediately after training with the muscarinic cholinerg
ic agonist oxotremorine, the muscarinic cholinergic antagonist atropin
e, the N-methyl-D-aspartate (NMDA) noncompetitive antagonist MK-801, o
r with a combination of MK-801 and one of the cholinergic agents. Oxot
remorine improved, while atropine and MK-801 impaired, memory retentio
n. In addition, oxotremorine attenuated, while atropine enhanced, the
effect of MK-801. The results show the existence of a glutamatergic-ch
olinergic interaction in modulating memory consolidation of mice.